Avalo Therapeutics, Inc. short interest in 2025
In 2025, Avalo Therapeutics, Inc.'s disclosed short interest ran from 1.08% of shares outstanding on 31 Mar 2025 to 14.17% on 31 Dec 2025, a change of +13.09 percentage points. The year's high was 14.17% on 31 Dec 2025 and its low 0.42% on 29 Aug 2025, averaging 3.78% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.56 days on 31 Dec 2025. Full history: Avalo Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 1.08% (31 Mar 2025)
- End of year
- 14.17% (31 Dec 2025)
- Change
- +13.09 pp
- High
- 14.17% (31 Dec 2025)
- Low
- 0.42% (29 Aug 2025)
- Average
- 3.78%
- Highest days to cover
- 7.56 (31 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2025 | 1.08% | 1.98 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 0.94% | 1.52 | |
| 30 Apr 2025 | 0.43% | 1.00 | |
| 15 May 2025 | 0.80% | 1.61 | 10-Q filed, results (8-K) |
| 30 May 2025 | 0.43% | 1.00 | |
| 13 Jun 2025 | 0.77% | 1.00 | |
| 30 Jun 2025 | 1.10% | 1.56 | |
| 15 Jul 2025 | 1.52% | 1.91 | |
| 15 Aug 2025 | 0.69% | 1.00 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 0.42% | 1.00 | |
| 14 Nov 2025 | 10.15% | 4.84 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.19% | 5.23 | |
| 15 Dec 2025 | 10.25% | 5.96 | |
| 31 Dec 2025 | 14.17% | 7.56 |
See also: Avalo Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.